Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancy

A R Morton, J A Cantrill, A E Craig, A Howell, M Davies, D C Anderson

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancy'. Together they form a unique fingerprint.

Medicine and Dentistry